Flu consultations increase 78% in a week

Flu consultations increase 78% in a week

January 15 2018 GPs saw over 21,700 cases of patients with influenza-like illness in the first...

New COPD pathway launched

New COPD pathway launched

January 12 2018 NHS RightCare has set out the core components of an optimal service for people...

MHRA warns of confusion over drug names and potential for errors

MHRA warns of confusion over drug names and potential for errors

January 11 2018 Healthcare professionals are being asked to be extra vigilant when prescribing or...

Co-dydramol strengths and herbal medicines among latest Drug Safety Update advice

Co-dydramol strengths and herbal medicines among latest Drug Safety Update advice

January 10 2018 The medicines regulator has highlighted the different strengths of co-dydramol in...

DVLA guidance on assessing patients with sleep apnoea updated

DVLA guidance on assessing patients with sleep apnoea updated

January 9 2018 The Primary Care Respiratory Society is flagging up changes to the driving...

  • Flu consultations increase 78% in a week

    Flu consultations increase 78% in a week

    Monday, 15 January 2018 10:57
  • New COPD pathway launched

    New COPD pathway launched

    Friday, 12 January 2018 14:53
  • MHRA warns of confusion over drug names and potential for errors

    MHRA warns of confusion over drug names and potential for errors

    Thursday, 11 January 2018 12:40
  • Co-dydramol strengths and herbal medicines among latest Drug Safety Update advice

    Co-dydramol strengths and herbal medicines among latest Drug Safety Update advice

    Wednesday, 10 January 2018 16:08
  • DVLA guidance on assessing patients with sleep apnoea updated

    DVLA guidance on assessing patients with sleep apnoea updated

    Tuesday, 09 January 2018 11:49

a pharmacist at computer imageJanuary 8 2018

The number of suspected drug reactions reported via the Yellow Card scheme in Wales rose 28% in 2016-17, with 2,330 reports made. This compares to 1,817 reports the previous year, and continues the upwards trend in reporting seen over the past four years.

The top ten drugs with the most reports associated with them were:

Drug No of associated reports 2015-16 No of associated reports 2016-17
rivaroxaban 107 121
dapagliflozin 49 120
Neisseria meningitidis preparations 18 92
apixaban 42 73
ramipril 29 44
canagliflozin 18 43
warfarin 23 43
amlodipine 27 42
omeprazole 25 38
sertraline 30 38

“GP reporters remained the highest reporting group and an increase of 12% was seen in the number of reports submitted by GPs compared with the previous year,” said the Yellow Card Centre Wales Annual Report. GPs contributed 972 reports, 42% of the total received.

The report also notes the increase in the number of reports submitted by pharmacists was 456%, reports from community pharmacists increased by 133%, while reports from members of the public rose 44%.

“The increase in the number of reports from GPs may be related to the continuation of Yellow Card reporting rates as a National Prescribing (reporting) Indicator in primary care and the integration of Yellow Card reporting into the clinical system support which is used in some practices,” says the report.

“The majority of reports from pharmacists originated from GP practice addresses and are therefore likely to have been submitted from those working as practice-based pharmacists.” Five had attended the Yellow Card Champion Training Day held in March 2017

Links:
All Wales Therapeutics & Toxicology Centre Yellow Card Centre Wales Annual Reports       
YCC Wales Annual Report 2016-2017      
MHRA Yellow Card site   

Professional News

January 18 2018 A new study has found no statin-related safety issues for statins being used to treat children with familial hypercholesterolaemia. However, the research has highlighted that many...
January 18 2018 A new study has found no statin-related safety issues for statins being used to treat children with familial hypercholesterolaemia. However, the research has highlighted that many...